Home » Topics » Regulatory

Regulatory
RSS

Prefilled syringe presentation of Copaxone launched

April 26, 2002

Xalatan approved in E.U. as first-line therapy for lowering IOP in glaucoma patients

April 24, 2002

Paxil CR launched in U.S.

April 23, 2002

Altocor filed for European marketing approval

April 22, 2002

FDA approves Botox Cosmetic for treatment of glabellar lines

April 19, 2002

NDA submitted for Eligard 30 mg for advanced prostate cancer

April 18, 2002

Arcoxia granted major approval for relief of arthritis and pain

April 17, 2002

Glivec approved in Switzerland for GISTs

April 17, 2002

FDA grants priority review to Arimidex in early breast cancer

April 17, 2002

Committee recommends approval of Cozaar to delay renal disease in type 2 diabetics

April 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...